Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.52 |
| ▸ | MAOB | P27338 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29020379 | 0.91 | ALDH1A1 (0.49) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL131516 | 0.89 | CYP19A1 (0.52) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL18893709 | 0.87 | MAOB (0.53) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL127705 | 0.83 | MAPT (0.52) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL7030025 | 0.83 | LMNA (0.48) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL11252782 | 0.83 | LMNA (0.53) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL11247779 | 0.82 | MAOB (0.49) | ABCG2ABCB1ARCYP19A1MAOB | |
| SCHEMBL7195895 | 0.82 | ALDH1A1 (0.50) | CYP19A1MAOBMAPTGABRA1GABRB2 | |
| SCHEMBL11242838 | 0.82 | LMNA (0.46) | ABCG2ABCB1ARCYP19A1MAOB | |
| Methoxymethane SCHEMBL27610365 | 0.81 | KDM4E (0.42) | ABCG2ABCB1ARCYP19A1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130959-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2026-05-14 | — | — | US | claimed |
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | claimed |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | claimed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| US-20220193162-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2022-06-23 | — | — | US | claimed |
| EP-3955946-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| WO-2020214801-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | Mycotechnology, Inc. (US) | 2020-10-22 | — | — | WO | claimed |
| CN-109890376-A | Composition is used in PGC-1 α activation | 三得利控股株式会社 | 2019-06-14 | — | — | CN | claimed |
| EP-0004579-B1 | FLAVANS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-08-18 | — | — | EP | claimed |
| US-20260033492-A1 | Pest Repellents and Uses Thereof | SENSORYGEN INC (US) | 2026-02-05 | — | — | US | disclosed |
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | disclosed |
| US-12280129-B2 | Compositions and methods for improved skin care | PINSKY MARK A (US) | 2025-04-22 | — | — | US | disclosed |
| CN-118649665-B | Preparation method of vacuum gas-phase derived chiral separation material | 宁波大学 | 2025-02-07 | — | — | CN | disclosed |
| US-12156832-B2 | Method, and system for multi-layer cosmetic pads and use thereof | ELC MANAGEMENT LLC (US) | 2024-12-03 | — | — | US | disclosed |
| US-6093411-A | AN EMULSION COMPRISING FLAVONOIDS FOR PREVENTING OR TREATING SKIN DISORDERS | THE PROCTER & GAMBLE COMPANY (US) | 2000-07-25 | — | — | US | disclosed |
| US-6051602-A | METHODS FOR PREVENTION OR TREATING SKIN DISORDERS USING FLAVONOID COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2000-04-18 | — | — | US | disclosed |
| WO-1999047118-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999047113-A1 | COMPOSITIONS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| WO-1999047119-A1 | METHODS FOR REGULATING SKIN APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033492-A1 | Pest Repellents and Uses Thereof | F3, TFPI, FLI1 | ABCG2 4389/4885ABCB1 2541/4885AR 4093/4885 |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | MMP1, COL1A1, SERPINB1 | ABCG2 4063/4885ABCB1 2698/4885AR 3364/4885 |
| US-20260130959-A1 | FUNGAL EXTRACTS AND FLAVOR COMBINATIONS THEREOF | TAS2R8, TAS2R40, TAS1R3 | ABCG2 1230/4885ABCB1 2615/4885AR 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.